Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine a safe dose of rIL-21 in combination with PLD, and to assess the efficacy of this combination in terms of overall response rate (RR).
Critère d'inclusion
- advanced epithelial Ovarian Cancer stage IIB-IV